article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

On the global stage, AI and Machine Learning (ML) drove drug discovery and process optimisation, especially as large-scale pharma companies adopted AI for precision medicine. Building sophisticated laboratories, recruiting scientific talent, and collaborating with global research institutions are essential steps in this process.

article thumbnail

What Pharmacies Need to Know About Amazon RxPass, a $5/ Month Generic Drug Subscription

Digital Pharmacist

Amazon RxPass Benefits There’s no denying that RxPass presents some rather enticing benefits for Prime members, which now is estimated to include 172 million Americans. Another potential problem is that patients might be considered non-compliant by their insurance company if they fill their medications out of network (ie: using RxPass).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Biogen admits slow Aduhelm launch, as scientists question label again

pharmaphorum

.” He blamed the poor performance on ” confusion, misinformation and controversy surrounding our data and the approval process.” Analysts think sales will be lacklustre ahead of the outcome of a review of coverage by the Center for Medicare and Medicaid Services (CMS), which isn’t expected until next year.

article thumbnail

NHC Comments on Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027 under Sections 11001 and 11002 of the IRA ICR Forms

Putting Patients First Blog

The NHC appreciates CMS’ efforts to gather patient-centered data as part of this ICR and its commitment to making the process more relevant for patients and patient organizations. While we acknowledge these improvements, it is important to note that some aspects of the data collection process may remain challenging.

article thumbnail

Frontiers Health Steering Committee spotlight: Eugene Borukhovich

pharmaphorum

In this latest coverage, pharmaphorum speaks with Eugene Borukhovich. He expects to see many new faces presenting, speaking in panel discussions, and much more: “That’s where you get the real deal information, right? The impacts of this, as we’ve seen, are insurers are on an acquisition spree at the moment,” Borukhovich says.

article thumbnail

External control arms and debunking real-world data myths

pharmaphorum

Christopher Boone, global head of health economics and outcomes research at AbbVie, advises: “Evidence generation in drug development is ripe for innovation in the digital era and the expanded use of real-world evidence presents a clear enabler to saving time and money.

article thumbnail

Pharmaceutical Market Access: Strategies, Challenges, and Key Trends for Success

Pharma Marketing Network

Pharmaceutical market access refers to the process of ensuring a drug is not only approved but also commercially viable, reimbursed, and accessible to patients. Rising Pricing Pressures and Cost Containment Governments and insurers are tightening cost controls to manage healthcare expenditures. Early negotiation of coverage agreements.